These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 26109099)
1. Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models. Kobayashi Y; Kashima H; Wu RC; Jung JG; Kuan JC; Gu J; Xuan J; Sokoll L; Visvanathan K; Shih IeM; Wang TL Clin Cancer Res; 2015 Oct; 21(20):4652-62. PubMed ID: 26109099 [TBL] [Abstract][Full Text] [Related]
2. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535 [TBL] [Abstract][Full Text] [Related]
3. Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance. Martirosyan A; Clendening JW; Goard CA; Penn LZ BMC Cancer; 2010 Mar; 10():103. PubMed ID: 20298590 [TBL] [Abstract][Full Text] [Related]
4. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo. Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175 [TBL] [Abstract][Full Text] [Related]
5. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression. Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979 [TBL] [Abstract][Full Text] [Related]
6. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer. Greenaway JB; Virtanen C; Osz K; Revay T; Hardy D; Shepherd T; DiMattia G; Petrik J Oncotarget; 2016 Jul; 7(30):47343-47365. PubMed ID: 27329838 [TBL] [Abstract][Full Text] [Related]
7. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma]. Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343 [TBL] [Abstract][Full Text] [Related]
8. Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents. Goard CA; Mather RG; Vinepal B; Clendening JW; Martirosyan A; Boutros PC; Sharom FJ; Penn LZ Int J Cancer; 2010 Dec; 127(12):2936-48. PubMed ID: 21351272 [TBL] [Abstract][Full Text] [Related]
10. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711 [TBL] [Abstract][Full Text] [Related]
11. BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model. Yu X; Luo Y; Zhou Y; Zhang Q; Wang J; Wei N; Mi M; Zhu J; Wang B; Chang H; Tang Y Int J Oncol; 2008 Sep; 33(3):555-63. PubMed ID: 18695886 [TBL] [Abstract][Full Text] [Related]
12. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells. Nilsson S; Huelsenbeck J; Fritz G Cancer Lett; 2011 May; 304(1):60-9. PubMed ID: 21356574 [TBL] [Abstract][Full Text] [Related]
13. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499 [TBL] [Abstract][Full Text] [Related]
14. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388 [TBL] [Abstract][Full Text] [Related]
15. Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis. Alonso DF; Farina HG; Skilton G; Gabri MR; De Lorenzo MS; Gomez DE Breast Cancer Res Treat; 1998 Jul; 50(1):83-93. PubMed ID: 9802623 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027 [TBL] [Abstract][Full Text] [Related]
17. RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Mabuchi S; Altomare DA; Connolly DC; Klein-Szanto A; Litwin S; Hoelzle MK; Hensley HH; Hamilton TC; Testa JR Cancer Res; 2007 Mar; 67(6):2408-13. PubMed ID: 17363557 [TBL] [Abstract][Full Text] [Related]
18. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Kindelberger DW; Lee Y; Miron A; Hirsch MS; Feltmate C; Medeiros F; Callahan MJ; Garner EO; Gordon RW; Birch C; Berkowitz RS; Muto MG; Crum CP Am J Surg Pathol; 2007 Feb; 31(2):161-9. PubMed ID: 17255760 [TBL] [Abstract][Full Text] [Related]
19. Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan. Munakata S; Yamamoto T Int J Gynecol Pathol; 2015 Jan; 34(1):9-18. PubMed ID: 25473747 [TBL] [Abstract][Full Text] [Related]
20. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Wen J; Shi JL; Shen DH; Chen YX; Song QJ Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]